Heparin - a Key Drug in the Treatment of the Circulatory Degenerative Diseases: Controlling its Action with Polymers

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|18|18|2591-2606

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.18, Iss.18, 2012-06, pp. : 2591-2606

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Stem Cells as a Novel Tool for Drug Screening and Treatment of Degenerative Diseases

By  

Current Pharmaceutical Design, Vol. 18, Iss. 18, 2012-06 ,pp. : 2644-2656

Bentham Science Publishers

Access to resources Recommend Favorite

Campylobacter vaccine development:a key to controlling enteric diseases

By Walker R.I.  

Expert Opinion on Investigational Drugs, Vol. 8, Iss. 2, 1999-02 ,pp. : 107-113

Informa Healthcare

Access to resources Recommend Favorite

AAV-Mediated Gene Supply for Treatment of Degenerative and Neovascular Retinal Diseases

By  

Current Gene Therapy, Vol. 10, Iss. 5, 2010-01 ,pp. : 371-380

Bentham Science Publishers

Access to resources Recommend Favorite

Antioxidant Properties of Melatonin and its Potential Action in Diseases

By  

Current Topics in Medicinal Chemistry, Vol. 15, Iss. 9, 2015-05 ,pp. : 894-903

Bentham Science Publishers

Access to resources Recommend Favorite

Getting an Insight into the Complexity of Major Chronic Inflammatory and Degenerative Diseases: A Potential New Systemic Approach to Their Treatment

By  

Current Pharmaceutical Biotechnology, Vol. 16, Iss. 9, 2015-01 ,pp. : 793-803

Bentham Science Publishers

Access to resources Recommend Favorite